Shanika Capital's Anmol Ganjoo sees Zydus Lifesciences, Granules India among potential pharma winner
CNBC-TV18
Anmol Ganjoo of Shanika Capital Advisors identifies Zydus Lifesciences and Granules India as top pharmaceutical sector picks.
Shanika Capital Advisors Managing Partner Anmol Ganjoo has highlighted Zydus Lifesciences and Granules India as potential winners in the pharmaceutical industry. He views Zydus Lifesciences as a strong option in the largecap space and Granules India as a preferred mid- and small-cap pick with multi-year growth drivers. Ganjoo's positive outlook comes despite existing concerns regarding a US FDA warning for Granules India.
Why it matters: The investment picks highlight potential growth opportunities and market sentiment within the Indian pharmaceutical sector despite regulatory challenges.






